YAP1 and cancer: Nearly three decades of intense research have established the involvement of the Hippo pathway and its effectors Yes-associated protein (YAP) and the paralog transcriptional co-activator with PDZ-binding domain (TAZ) in shaping organ size control, tissue homeostasis, stem cell fate and cancer [1].